Mainolfi Nello bought KYMR
December 31, 2025 · Form 4 insider transaction
Mainolfi Nello bought 30,000 shares of Kymera Therapeutics, Inc. at $2.08 per share, a transaction worth $62.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$2.08
Total value
$62.4K
InsiderMainolfi Nello
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 31, 2025
Filing dateDecember 31, 2025
Shares owned after693,077
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person.